Humalog Mix 25 And Humalog Mix 50 100 units/ml Suspension for injection
PDF Leaflet Revision Date: 13 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
For treatment of diabetes mellitus requiring insulin.
Dosage (summary)
Determined by healthcare professional; administer subcutaneously before or after meals.
Onset of Action / Duration
Onset: 15 mins, Duration: ~15 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Paediatric population
Pregnancy & Breastfeeding
Generally safe in pregnancy; insulin needs may change. Monitor breastfeeding patients for dose adjustments.
Key Drug Interactions
- Hyperglycaemic agents (e.g., corticosteroids)
- Hypoglycaemic agents (e.g., oral hypoglycaemics)
- Pioglitazone (risk of heart failure)
Contraindications
- Hypersensitivity to insulin lispro
- Hypoglycaemia
Common side effects
- Hypoglycaemia
- Local allergy
- Lipodystrophy
Counselling Points
- Educate on proper injection techniques
- Rotate injection sites
- Monitor blood glucose regularly
Serious warnings
- Risk of hypoglycaemia and hyperglycaemia
- Injection site reactions
Important Disclaimer
The Humalog Mix 25 And Humalog Mix 50 100 units/ml Suspension for injection professional information leaflet below is the property of Eli Lilly (SA) and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
